UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Factors associated with acute esophagitis during radiation therapy for lung cancer

Radiotherapy and oncology, 2024-08, Vol.197, p.110349, Article 110349

2024

Link zum Volltext

Verfügbarkeit prüfen

Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial

International journal of radiation oncology, biology, physics, 2022-07, Vol.113 (4), p.732-741

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining a radiotherapy target with positron emission tomography

International journal of radiation oncology, biology, physics, 2004-11, Vol.60 (4), p.1272-1282

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium

Practical Radiation Oncology, 2022-09, Vol.12 (5), p.e376-e381

2022

Link zum Volltext

Verfügbarkeit prüfen

Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative

Practical Radiation Oncology, 2023-09, Vol.13 (5), p.444-453

2023

Link zum Volltext

Verfügbarkeit prüfen

ACR appropriateness criteria[R]: nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent

Oncology (Williston Park, N.Y.), 2014-08, Vol.28 (8), p.704

2014

Link zum Volltext

Verfügbarkeit prüfen

Trends in Cervical Cancer Treatment in the United States, With Focus on Treatment With Brachytherapy With Analysis of Variables and Possible Differences Between 11 Geographic Areas in the USA

Brachytherapy, 2015, Vol.14 (1), p.93-93

2015

Link zum Volltext

Verfügbarkeit prüfen

Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals

Practical Radiation Oncology, 2013-01, Vol.3 (1), p.67-73

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictors of early hospice or death in patients with inoperable lung cancer treated with curative intent

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20525-e20525

2021

Link zum Volltext

Verfügbarkeit prüfen

American Radium Society® (ARS) Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer (NSCLC)

International journal of radiation oncology, biology, physics, 2020-10, Vol.108 (2), p.E48-E48

2020

Link zum Volltext

Verfügbarkeit prüfen

American Radium Society (ARS) and American College of Radiology (ACR) Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer (NSCLC)

International journal of radiation oncology, biology, physics, 2020-10, Vol.108 (2), p.E48-E49

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcome and Late Toxicity Analysis for Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy

Brachytherapy, 2011, Vol.10, p.S97-S97

2011

Link zum Volltext

Verfügbarkeit prüfen

Excellent Ten-Year Results following Accelerated Partial Breast Irradiation with Multicatheter Interstitial Brachytherapy in Unsuitable Patients as Categorized by the American Society of Therapeutic Radiology and Oncology Consensus Panel

Brachytherapy, 2010, Vol.9, p.S23-S23

2010

Link zum Volltext

Verfügbarkeit prüfen

Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for High-Risk Prostate Cancer

Brachytherapy, 2011, Vol.10, p.S28-S29

2011

Link zum Volltext

Verfügbarkeit prüfen

Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for Intermediate-Risk Prostate Cancer

Brachytherapy, 2011, Vol.10, p.S30-S31

2011

Link zum Volltext

Verfügbarkeit prüfen

High-Dose-Rate Re-Irradiation with Continuous Hyperthermia for Recurrent Prostate Cancer

Brachytherapy, 2010, Vol.9, p.S72-S72

2010

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Partial Breast Irradiation for Pure Ductal Carcinoma In Situ

Brachytherapy, 2010, Vol.9, p.S39-S39

2010

Link zum Volltext

Verfügbarkeit prüfen

Is the Phoenix Biochemical Failure Definition Accurate for Prostate Cancer Patients Treated with Brachytherapy Alone?

Brachytherapy, 2010, Vol.9, p.S29-S29

2010

Link zum Volltext

Verfügbarkeit prüfen

Dose Escalated Hypofractionated Radiotherapy Improves Cancer Related Events for High-Intermediate and High-Risk Prostate Cancer Patients at 10 Years

Brachytherapy, 2010, Vol.9, p.S56-S56

2010

Link zum Volltext

Verfügbarkeit prüfen

Chronic Toxicity Profile of Hypofractionated, High-Dose-Rate Brachytherapy Boost with Pelvic External Beam Radiation Therapy for Intermediate- and High-Risk Prostate Cancer

Brachytherapy, 2010, Vol.9, p.S30-S30

2010

Link zum Volltext

Verfügbarkeit prüfen

Higher rate of prostate-specific antigen bounce ≥2 ng/mL with brachytherapy in young prostate cancer patients

Brachytherapy, 2009-04, Vol.8 (2), p.172-172

2009

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Dose Accuracy in the Near-Surface Region for Whole Breast Irradiation Techniques in a Multi-institutional Consortium

Practical Radiation Oncology, 2022-07, Vol.12 (4), p.e317-e328

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of defining the gross tumor volume with combination of CT and {sup 18}FDG-positron emission tomography in non-small-cell lung cancer

International journal of radiation oncology, biology, physics, 2007-03, Vol.67 (3)

2007

Link zum Volltext

Verfügbarkeit prüfen

Does brachytherapy reduce morbidity compared to external beam adaptive radiotherapy or pelvic irradiation with brachytherapy boost for localized prostate cancer?

Brachytherapy, 2008, Vol.7 (2), p.118-118

2008

Link zum Volltext

Verfügbarkeit prüfen

Long‐term cosmetic results and toxicity after accelerated partial‐breast irradiation

Cancer, 2006-03, Vol.106 (5), p.991-999

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(61)
Buchkapitel
(1)

Sprache

Englisch
(62)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Factors associated with acute esophagitis during radiation therapy for lung cancer

Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial

Defining a radiotherapy target with positron emission tomography

Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium

Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative

ACR appropriateness criteria[R]: nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent

Trends in Cervical Cancer Treatment in the United States, With Focus on Treatment With Brachytherapy With Analysis of Variables and Possible Differences Between 11 Geographic Areas in the USA

Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals

Predictors of early hospice or death in patients with inoperable lung cancer treated with curative intent

American Radium Society® (ARS) Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer (NSCLC)

American Radium Society (ARS) and American College of Radiology (ACR) Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer (NSCLC)

Long-Term Outcome and Late Toxicity Analysis for Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy

Excellent Ten-Year Results following Accelerated Partial Breast Irradiation with Multicatheter Interstitial Brachytherapy in Unsuitable Patients as Categorized by the American Society of Therapeutic Radiology and Oncology Consensus Panel

Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for High-Risk Prostate Cancer

Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for Intermediate-Risk Prostate Cancer

High-Dose-Rate Re-Irradiation with Continuous Hyperthermia for Recurrent Prostate Cancer

Accelerated Partial Breast Irradiation for Pure Ductal Carcinoma In Situ

Is the Phoenix Biochemical Failure Definition Accurate for Prostate Cancer Patients Treated with Brachytherapy Alone?

Dose Escalated Hypofractionated Radiotherapy Improves Cancer Related Events for High-Intermediate and High-Risk Prostate Cancer Patients at 10 Years

Chronic Toxicity Profile of Hypofractionated, High-Dose-Rate Brachytherapy Boost with Pelvic External Beam Radiation Therapy for Intermediate- and High-Risk Prostate Cancer

Higher rate of prostate-specific antigen bounce ≥2 ng/mL with brachytherapy in young prostate cancer patients

Evaluation of Dose Accuracy in the Near-Surface Region for Whole Breast Irradiation Techniques in a Multi-institutional Consortium

Clinical implications of defining the gross tumor volume with combination of CT and {sup 18}FDG-positron emission tomography in non-small-cell lung cancer

Does brachytherapy reduce morbidity compared to external beam adaptive radiotherapy or pelvic irradiation with brachytherapy boost for localized prostate cancer?

Long‐term cosmetic results and toxicity after accelerated partial‐breast irradiation

Aktive Filter

Suchergebnisse filtern